| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Amneal Pharmaceuticals, Inc.'s insiders have reduced their positions by a net 413,016 shares worth roughly $7.2M.
AMRX sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 61.34M | - | - | |
| CEO | 6.38M | - | - | |
| CEO | 6.38M | - | - | |
| Dir | 832.8K | - | - | |
| CFO | 449.4K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14, 2025 | Patel Tushar Bhikhubhai | - | Sell | 5,000,000 | $8.35 | $41,750,000.00 | -9.3% | -9.0% | +35.2% | |
| Mar 6, 2025 | Daly Jason B. | EVP, Chief Legal Officer | Sell | 90,000 | $8.80 | $792,159.60 | -73.4% | -17.7% | +51.1% | |
| Mar 5, 2025 | Boyer Andrew S | Executive Vice President | Sell | 125,000 | $8.89 | $1,111,250.00 | -30.1% | -16.9% | +47.9% | |
| Mar 5, 2025 | Konidaris Tasos | Executive Vice President &CFO | Sell | 100,000 | $8.91 | $891,000.00 | -13.9% | -16.9% | +47.9% | |
| Mar 5, 2025 | Alva Emily Peterson | Director | Sell | 80,000 | $8.90 | $712,000.00 | -31.9% | -16.9% | +47.9% | |
| Mar 3, 2025 | Patel Gautam | Director | Sell | 80,000 | $8.90 | $712,000.00 | -4.2% | -15.3% | +52.1% | |
| Feb 3, 2025 | Patel Gautam | Director | Sell | 80,000 | $8.14 | $651,200.00 | -4.1% | -7.8% | +74.2% | |
| Jan 8, 2025 | Patel Gautam | Director | Sell | 62,590 | $8.01 | $501,345.90 | -3.1% | -13.3% | +63.8% | |
| Jan 2, 2025 | Patel Gautam | Director | Sell | 17,410 | $8.01 | $139,454.10 | -0.8% | +5.3% | +63.1% | |
| Nov 22, 2024 | Kiely John | Director | Sale+OE | 17,058 | $8.38 | $142,946.04 | -6.0% | -6.2% | +42.4% |